News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Patel Sushil
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Patel Sushil (Chief Strategy Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 5,145 shares
@ $24.11, valued at
$124k
Sold 553 shares
@ $23.44, valued at
$13k
|
|
| 06/12/2023 |
4
| Patel Sushil (Director) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Granted 5,200 shares
@ $0
Granted 18,400 options to buy
@ $24.84, valued at
$457.1k
|
|
| 05/18/2023 |
4
| Patel Sushil (Chief Strategy Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 15,575 shares
@ $18.05, valued at
$281.1k
|
|
| 04/04/2023 |
4
| Patel Sushil (Chief Strategy Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 60,000 options to buy
@ $17.66, valued at
$1.1M
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Patel Sushil (Chief Commercial Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 52,500 shares
@ $0
Granted 78,750 options to buy
@ $18.26, valued at
$1.4M
|
|
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|